Delivery Order SPE2DR25D2100-SPE2DR26FA1AJ
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package. This is a firm fixed price delivery order with a ceiling value of $3,275.55 and an ultimate completion date of October 20, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a contract ceiling value of $2,447.59. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set for ultimate completion by January 7, 2026, and performance will be executed from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) with a ceiling value of $4,885.54. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and is scheduled for completion by August 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $8,059.34 delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The award is non-competitive and structured as a firm fixed price delivery order, with an ultimate completion date of May 19, 2025. Performance of this contract will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,595.10 on December 16, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 17, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded without set-aside provisions, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $8,736.12 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets in quantities of 30 units. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $23,688.39 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ondansetron ODT (orally disintegrating tablets) 8mg in a 30-count quantity. This is a firm fixed-price, competitively awarded contract with a completion date of December 12, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a $7,153.44 delivery order to AmerisourceBergen Drug Corp for 30-count packages of Ondansetron ODT 4 mg tablets, with performance completion targeted for October 29, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The place of performance is listed as the vendor's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,077.50 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units). This competitive, firm fixed-price delivery order was issued on December 22, 2025, with an ultimate completion date of December 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a $9,977.26 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count) with an ultimate completion date of December 24, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA1AJDelivery Order
The Defense Logistics Agency awarded a $5,724.72 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which is set to be completed by January 7, 2026, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete on a full and open basis for federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This strategic vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications across multiple therapeutic domains. The ondansetron tablets being procured under this order serve as an anti-nausea medication commonly used in military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 1/5/26 |